Robot-assisted minimally-invasive CABG surgery

Dr. Robert Poston is a pioneer in the use of robotics for minimally invasive cardiac surgery. He recently joined BMC as chief of cardiac surgery. With his arrival, BMC has become one of only one of 9 hospitals across the country, and the only hospital in Boston, to offer robot-assisted minimally invasive coronary artery bypass, the most advanced treatment available for coronary artery disease (the most common form of heart disease - 16 million Americans have -- and the leading cause of death - 1 million/year --in the U.S.)

For patients with severe blockages, coronary artery bypass graft surgery (cabg) allows surgeons to remove or re-direct a blood vessel from one part of the body and place it around the obstructed part of the artery, effectively by-passing it, and restoring blood flow to the heart muscle.

Mininally invasive, robotically-assisted bypass surgery allows physicians to gain access to the heart with several small incisions, unlike conventional bypass surgery which requires the chest to be opened with a 6-10 inch incision at the breastbone (sternum.)

Using small incisions between the ribs, the arms of the robot and a small camera are placed to allow the surgeon to look through lenses on a computer console that provide a 3-dimentional, 10-times-magnified image inside the patient's body.

The surgeon's hands control the instrument's arms to perform the procedure. The robot's "wristed" instruments effectively mimic the movements of the surgeon's hands and wrist, providing the surgeon with flexibility and precise motion control as he 'harvests' one or more blood vessels from inside the chest cavity, to redirect one end to the heart surface beyond the blockage, bypassing the blockage, to restore blood flow to the heart.

In addition to smaller incisions (and smaller scars) the patient benefits are fewer side effects and complications, less pain, reduced risk of infection and faster recovery.

Source: Boston University

Related stories:

Safety in numbers for community hospitals performing emergency angioplasty
Heart experts at Johns Hopkins have evidence that life-saving coronary angioplasty at community hospitals is safer when physicians and hospital staff have more experience with the procedure.
Study: Concerns on mixing Plavix, heartburn drugs
(AP) -- Stent patients who take the blood thinner Plavix along with certain heartburn drugs may face a greater risk of heart attack, stroke and other dangerous events, according to a study released Tuesday.
Cell-coated stent as effective as drug-coated ones but needs less meds
A stent that entices artery-lining cells to coat it works as well or better than drug-eluting stents in keeping arteries open in coronary heart disease patients, according to two research studies presented at the American Heart Association's Scientific Sessions 2008.
Studies: Elderly fare well in open-heart surgery
(AP) -- Eighty-year-olds with clogged arteries or leaky heart valves used to be sent home with a pat on the arm from their doctors and pills to try to ease their symptoms. Now more are getting open-heart surgery, with remarkable survival rates rivaling those of much younger people, new studies show.
No drop in IQ seen after bypass for child heart surgery
The use of cardiopulmonary bypass does not cause short-term neurological problems in children and teenagers after surgery for less complex heart defects, according to pediatric researchers. The new finding contrasts favorably with previous studies that showed adverse neurological effects after newborn surgery for more complex heart conditions.
Hispanics less likely to have repeat revascularizations 1 year after angioplasty
Hispanic patients were 57 percent less likely than Caucasian patients to undergo coronary artery bypass surgery (CABG) one year after successful angioplasty, a type of percutaneous coronary intervention (PCI) to open blockages in the coronary arteries. Hispanics also had a trend toward lower rates of overall repeat revascularization procedures including stenting and bypass surgery, according to a study presented at the American Heart Association's Scientific Sessions 2008.
Drug trial shows dramatic reduction in hidden heart disease
(PhysOrg.com) -- A Harvard-led study shows that the risk of heart attack and stroke among subjects with “silent heart disease” — and normal cholesterol levels — can be dramatically reduced by the use of an already widely prescribed class of drugs.
Despite failures, search for obesity drugs still looks golden
Designers of anti-obesity drugs have suffered three major setbacks, but the potential reward from treating the world's fat epidemic is so great that their quest is unlikely to be deterred.

News discussion:

Medicine & Health news